Et lavt transferrinmetningsresultat betyr at det er for lite sirkulerende jern tilgjengelig for vev, men det betyr ikke automatisk at jernlagrene er uttømte. Kombinasjonen av TSAT, ferritin, CBC, CRP, nyrefunksjon, tidspunkt og symptomer forteller den nyttige kliniske historien.
- Lav TSAT er vanligvis under 20%, mens mange laboratorier bruker et voksent referanseintervall på omtrent 20% til 45%.
- TSAT-formel er serumjern delt på total jernbindende kapasitet, multiplisert med 100; den gjenspeiler jern som er umiddelbart tilgjengelig i sirkulasjonen.
- Alene serumjern kan falle med 30% eller mer i løpet av dagen, så én enkelt lav verdi er mindre pålitelig enn et samsvarende mønster av jern, TIBC, ferritin og CBC.
- Tidlig jernmangel kan gi TSAT under 20% mens ferritin fortsatt ligger innenfor et laboratoriets referanseintervall.
- Inflammasjon kan senke serumjern og TSAT mens ferritin forblir normalt eller høyt fordi ferritin øker som et akuttfaseprotein.
- Ferritin under 15 ng/mL er svært spesifikt for fravær av jernlagre; mange klinikere undersøker verdier under 30 ng/mL når symptomer eller anemi er til stede.
- CKD-related iron restriction is commonly considered when TSAT is 30% or lower, although treatment decisions also depend on ferritin, hemoglobin, ESA use, and dialysis status.
- Akutte symptomer such as chest pain, fainting, breathlessness at rest, black stools, or heavy ongoing bleeding need prompt medical assessment rather than self-treatment.
Hva et lavt transferrinmetningsresultat faktisk måler
Low transferrin saturation usually means that less than 20% of the iron-carrying protein transferrin is occupied by iron, leaving too little readily available iron for red-cell production and other tissues. It is a measure of iron availability, not a direct inventory of every milligram of stored iron.
TSAT beregnes som serum iron ÷ total iron-binding capacity (TIBC) × 100. A serum iron of 40 µg/dL and TIBC of 320 µg/dL gives a TSAT of 12.5%, which is low in most adult laboratories. That calculation explains why the same serum iron can mean different things when TIBC changes.
When I review a panel showing TSAT of 14%, I do not call it iron deficiency until I see ferritin, hemoglobin, MCV, RDW, CRP or ESR, creatinine, and the clinical timeline. Kantesti is an AI blood test analyzer that reads TSAT alongside its denominator, ferritin, CBC indices, and prior results rather than treating a low percentage as a diagnosis. Vår biomarkørreferanseguide helps patients see why one isolated flag rarely settles the question.
Transferrin is made largely in the liver, and its concentration can rise when iron stores fall or decline with inflammation, liver synthetic dysfunction, protein loss, and poor nutrition. Thus, a low TSAT can result from low serum iron, high TIBC, or both; a person with liver disease may even have a deceptively ordinary TSAT because TIBC is low. That denominator is the part many reports hide in plain sight.
Why the percentage can be more revealing than serum iron
TSAT captures the relationship between iron supply and iron-carrying capacity, whereas serum iron is only a momentary concentration. In clinical practice, a TSAT of 11% with TIBC 410 µg/dL points in a different direction from TSAT of 11% with TIBC 150 µg/dL, even though both deserve follow-up.
Hvilke transferrinmetningsverdier er lave?
Most adult laboratories consider TSAT below 20% low, and values below 16% more strongly suggest restricted iron delivery to the bone marrow. Reference limits vary by assay, age, pregnancy status, and whether the sample was collected during acute illness.
A practical adult reference interval is often 20% to 45%, though some UK and European laboratories report 15% to 50%. A result of 19% is not automatically dangerous, but it becomes meaningful when ferritin is falling, hemoglobin is below range, MCV is trending downward, or fatigue has persisted for months.
Values below 10% deserve more timely attention, particularly with anemia, pregnancy, chronic kidney disease, inflammatory bowel disease, or symptoms limiting normal activity. I have seen endurance athletes with hemoglobin still at 13.2 g/dL but TSAT of 9%, ferritin of 18 ng/mL, and a clear decline in training tolerance over a single season.
Laboratory cutoffs are screening tools rather than biological cliff edges. The deeper explanation of assay methods and the TIBC calculation is in our iron studies guide; use your reporting laboratory's interval first when discussing a result with a clinician.
Lav TSAT versus lavt serumjern: hvorfor de ikke er det samme
Lavt serumjern er en enkelt, svingende måling, mens lav TSAT justerer denne jernverdien for mengden transferrin som er tilgjengelig for å transportere det. Et lavt jernresultat kan forekomme etter en vanlig overnattingsfaste, en prøvetaking på ettermiddagen, nylig trening, infeksjon eller inflammasjon uten at det beviser jernlageruttømming.
Serumjern har betydelig døgnvariasjon og er ofte høyere om morgenen enn senere på dagen; nylig peroral jernbehandling kan midlertidig øke det i flere timer. Hos en pasient som tok en 65 mg elementært jern-tablett før en ettermiddagstest, kan serumjern se betryggende ut, mens ferritin og trenden før behandlingen fortsatt viser et reelt underskudd. En veiledning for TIBC- klargjøring kan forhindre denne vanlige kilden til forvirring.
Lavt serumjern med normal TSAT kan forekomme når TIBC er redusert, slik som ved inflammasjon, avansert leversykdom eller lave transferrintilstander. Omvendt kan serumjern i den nedre delen av normalområdet sameksistere med TSAT under 20% hvis TIBC er høy, noe som er et velkjent tidlig mønster ved absolutt jernmangel.
Det praktiske spørsmålet er ikke “er jernet lavt?” men “når nok jern frem til benmargen, og hvorfor ikke?” I min erfaring er det mer informativt å gjenta et komplett jernpanel under sammenlignbare forhold enn å jage små forskjeller som serumjern på 52 versus 61 µg/dL.
Tidlig jernmangel kan forekomme med normal ferritin
Lav TSAT med ferritin fortsatt innenfor laboratoriets referanseområde kan representere tidlig absolutt jernmangel, særlig når ferritin er 15–30 ng/mL og TIBC øker. Ferritin er en lagringsmarkør, men det brede referanseområdet i befolkningen er ikke en garanti for at lagrene er tilstrekkelige for hver pasient.
Ferritin below 15 ng/mL er svært spesifikt for jernmangel hos ellers friske voksne, men Verdens helseorganisasjons (WHO) ferritin-retningslinje fra 2020 anerkjenner at inflammasjon endrer tolkningen. Mange hematologer bruker en praktisk terskel under 30 ng/mL for å støtte jernmangel hos en person med kompatible symptomer eller anemi, fordi uttømming ofte begynner før laboratorieflagget vises (World Health Organization, 2020).
Et representativt tidlig mønster er ferritin 26 ng/mL, TSAT 17%, TIBC 390 µg/dL, hemoglobin 12,8 g/dL, MCV 84 fL og økende RDW. Personen kan ha normalt hemoglobin i dag, men synkende jernreserver i løpet av 6 til 12 måneder; menstruasjonstap, blodgivning, restriktiv spising, distanseløping eller malabsorpsjon kan alle passe. Vår artikkel om ferritinnivåer hos kvinner forklarer hvorfor menstruasjonshistorien er klinisk viktig.
Jeg er varsom med å behandle et antall uten å identifisere årsaken. Kantesti er en plattform for tolkning av AI-blodprøver som sammenligner ferritin, TSAT, TIBC, hemoglobin og langsgående drift for å flagge et mulig tidlig mangelmønster for klinikerens vurdering. Per 3. august 2026 bør ingen anerkjent tolkningssystem presentere dette mønsteret som en erstatning for å vurdere blødning, kosthold, graviditet, medisiner og gastrointestinale symptomer.
Hvordan inflammasjon forårsaker lav TSAT med normal eller høy ferritin
Inflammasjon kan gi lav TSAT til tross for normal eller forhøyet ferritin, fordi hepcidin «fanger» jern inne i lagringsceller og reduserer eksport av jern fra tarmen. Dette kalles ofte funksjonell jernmangel eller jernrestriktiv erytropoiese, selv om terminologien varierer mellom fagområder.
Interleukin-6 stimulates liver production of hepcidin, which binds the iron exporter ferroportin and reduces iron release from enterocytes and macrophages. Serum iron and TSAT can therefore fall within hours to days of infection, autoimmune activity, major surgery, obesity-related inflammation, or cancer, while ferritin rises as an acute-phase reactant.
A ferritin of 110 ng/mL does not rule out iron-restricted erythropoiesis when CRP is elevated and TSAT is 13%. In contrast, ferritin 110 ng/mL with CRP below 3 mg/L, stable hemoglobin, and TSAT 28% is much less suggestive of an iron supply problem. The relationship is explored in our guide to ferritin and CRP patterns.
This is one of those areas where context matters more than a universal cutoff. Kantesti AI is an AI-powered blood test analysis tool that identifies the low-TSAT, raised-CRP, non-low-ferritin combination as an inflammatory pattern rather than simply recommending iron. Oral iron may be poorly absorbed while hepcidin is high, and treating an underlying inflammatory disorder may change the laboratory picture.
Blodtap er en ledende årsak til lav jernmetning
Ongoing blood loss is one of the most common low transferrin saturation causes, particularly heavy menstrual bleeding and slow gastrointestinal loss. In adult men and postmenopausal women, confirmed iron-deficiency anemia requires a deliberate search for a cause rather than assuming diet alone.
Heavy menstrual bleeding is clinically relevant when periods last more than 7 days, require changing protection every 1 to 2 hours, involve frequent large clots, or cause flooding through clothing or bedding. Frequent blood donation can also remove about 200-250 mg of iron per whole-blood donation, enough to lower ferritin before hemoglobin triggers a deferral.
Gastrointestinal sources include peptic ulcer disease, coeliac disease, inflammatory bowel disease, colorectal polyps or cancer, hemorrhoids, and regular NSAID use. The American Gastroenterological Association advises bidirectional endoscopy for most asymptomatic men and postmenopausal women with iron-deficiency anemia, and suggests it for premenopausal women after shared decision-making (Ko et al., 2020). A low ferritin without obvious menstrual loss deserves a GI and diet review.
Black, tarry stool, vomiting material resembling coffee grounds, rectal bleeding, progressive abdominal pain, unexplained weight loss, or rapidly worsening weakness should not wait for a supplement trial. A low TSAT itself is not an emergency, but it can be the quiet laboratory clue that points toward a source of iron loss worth finding.
Kosthold, absorpsjonsproblemer og medisiner som senker jernets tilgjengelighet
Low dietary iron intake and reduced absorption can lower TSAT, but they rarely explain a persistent abnormal result without looking at losses, gut health, and medications. Heme iron from meat and fish is generally absorbed more efficiently than non-heme iron from plants, yet well-planned plant-based diets can still meet needs.
Vitamin C-rich foods can improve non-heme iron absorption, while tea, coffee, calcium supplements, and high-phytate foods can reduce absorption when consumed with the same meal. The effect is usually modest across an entire diet, but it matters when iron reserves are already low; separating tea or coffee from an iron-rich meal by 1 to 2 hours is a reasonable practical step.
Coeliac disease, autoimmune gastritis, Helicobacter pylori infection, bariatric surgery, chronic diarrhea, and inflammatory bowel disease can all impair iron uptake. Long-term proton-pump inhibitors may contribute in susceptible people by reducing gastric acidity, though they are seldom the only explanation for a TSAT of 8%. Nutrient patterns such as coexisting folate or B12 issues deserve attention; see our guide to low folate causes.
Diet changes should support treatment, not postpone evaluation of severe deficiency or blood loss. A person with ferritin 7 ng/mL and hemoglobin 9.4 g/dL usually needs a clinician-led plan beyond adding spinach, lentils, or fortified cereal.
Nyresykdom og kronisk sykdom: det lave TSAT-mønsteret
Chronic kidney disease often causes low TSAT through both reduced erythropoietin activity and inflammation-driven iron restriction. In CKD, ferritin can be normal or high even when marrow iron delivery is inadequate.
The KDIGO anemia guideline suggests considering iron therapy in adults with CKD and anemia when TSAT is 30% or lower and ferritin is 500 ng/mL or lower, provided a rise in hemoglobin or reduction in erythropoiesis-stimulating therapy is desired (KDIGO, 2012). These are treatment thresholds, not proof that every person below them has absolute iron deficiency.
Heart failure, rheumatoid arthritis, chronic infection, cancer, and inflammatory bowel disease can create similar iron-restricted patterns. In heart failure research and many cardiology services, ferritin below 100 ng/mL, or ferritin 100-299 ng/mL with TSAT below 20%, is used to define iron deficiency; that definition should not be automatically copied into an otherwise healthy outpatient.
Creatinine, eGFR, urine albumin, hemoglobin, reticulocytes, CRP, and medication history change the interpretation substantially. Our CKD-stadieguide explains why an eGFR result is part of the same clinical conversation, not a separate issue.
CBC-funn som gjør lav TSAT mer overbevisende
Low TSAT becomes more clinically persuasive when the CBC shows falling hemoglobin, a low MCV, low MCH, or an increasing RDW. These changes often emerge gradually and may lag behind declining iron availability by weeks or months.
Iron deficiency classically causes microcytosis, meaning MCV below about 80 fL in adults, but MCV can remain normal early on or when B12 deficiency, alcohol exposure, liver disease, or thalassemia trait is also present. Hemoglobin below 12.0 g/dL in nonpregnant adult women and below 13.0 g/dL in adult men meets common WHO anemia criteria, although altitude and pregnancy alter interpretation.
RDW often rises before MCV falls because the marrow produces a mixture of older normal-sized cells and newer smaller cells. A rising RDW after iron treatment can also be a recovery signal, not a failure, because newly produced cells differ in size from pre-existing cells. Our explanation of RDW after iron therapy covers that counterintuitive phase.
A low MCV with a relatively high red-cell count can suggest thalassemia trait rather than iron deficiency, and the two conditions can coexist. Kantesti AI interprets a low TSAT with CBC indices as a pattern that may need ferritin confirmation or hemoglobinopathy testing, not as a reason to prescribe iron blindly.
Symptomer ved lav transferrinmetning: hva folk faktisk merker
Low transferrin saturation may cause fatigue, reduced exercise tolerance, poor concentration, headaches, cold sensitivity, restless legs, and hair shedding, but many people have no symptoms at all. Symptoms become more likely when low TSAT persists or progresses to anemia.
Fatigue from iron deficiency is not simply “being tired.” Patients often describe a new mismatch between effort and recovery: stairs feel disproportionately hard, running pace drops at the same heart rate, or a familiar workday leaves them mentally spent. These symptoms overlap with sleep loss, depression, thyroid disease, infection, B12 deficiency, and cardiopulmonary conditions.
Restless legs has a particularly useful iron connection. Several sleep-medicine guidelines consider iron replacement when ferritin is below 75 ng/mL in people with clinically significant restless legs, often aiming for a higher threshold than is used to define anemia; this should be individualized, especially in inflammation or kidney disease.
Breathlessness at rest, fainting, persistent racing heartbeat, chest pressure, or inability to carry out ordinary activity are not symptoms to attribute to iron alone. A focused dizziness blood-test review can help frame the differential, but acute symptoms need real-time clinical assessment.
Hvordan gjenta et jernpanel uten å villede resultatene
A repeat iron panel is most useful when collected at a similar morning time, when you are not acutely unwell, and after avoiding non-prescribed iron shortly before the draw if your clinician agrees. There is no universal fasting rule, but consistency makes serial results easier to interpret.
For a stable outpatient reassessment, I usually prefer a morning sample after an overnight fast of roughly 8–12 timer, with the laboratory and prescriber aware of any iron tablets, multivitamins, vitamin C, intravenous iron, or recent transfusion. Do not stop prescribed medication without instruction, particularly in pregnancy, CKD, or known anemia.
Delay routine iron studies during a fever, immediately after a marathon, within days of major surgery, or during an active inflammatory flare when possible. Such states can lower serum iron and TSAT through hepcidin even if body iron has not materially changed. The practical details are covered in our guide to fasting and supplements.
Trend quality matters more than a single decimal point. Thomas Klein, MD, advises patients to save the draw time, fasting status, period timing, donation date, exercise in the previous 48 hours, illness, and supplement dose beside each panel; these small details often explain an apparent laboratory contradiction.
Hvilke oppfølgingsprøver avklarer et lavt TSAT-resultat?
Ferritin, CBC with indices, CRP or ESR, reticulocyte count, creatinine/eGFR, and a careful bleeding history clarify most low TSAT results. Soluble transferrin receptor, reticulocyte hemoglobin content, coeliac serology, and stool or endoscopic evaluation are selected when the basic pattern remains uncertain.
Soluble transferrin receptor usually rises in absolute iron deficiency and is less distorted by inflammation than ferritin, although assay availability and reference ranges vary. The , can be useful in specialist settings, but it is not standardized enough to replace a conventional iron panel in every primary-care patient. Our guide explains when a testen for løselig transferrinreseptor adds real value.
Reticulocyte hemoglobin content, variously called CHr or Ret-He, estimates iron available for newly made red cells over the preceding few days. A low result can reveal iron-restricted erythropoiesis earlier than mature-cell indices, especially in CKD and dialysis care, though the cutoff is analyzer-specific and commonly lies around 28-30 pg.
Kantesti is an AI lab test interpretation service that organizes iron studies with inflammation markers, renal function, CBC trends, and reported context so the next question is explicit. Readers interested in how contextual analysis is reviewed can see our kliniske valideringsstandarder, but a concerning pattern still needs clinician-led diagnosis and source investigation.
Neste steg: behandle årsaken, ikke bare den lave prosentandelen
The right treatment for low TSAT depends on whether the problem is depleted stores, blood loss, poor absorption, inflammation, CKD, or a mixed pattern. Taking iron without identifying the cause can delay recognition of gastrointestinal disease, ongoing heavy bleeding, or inflammatory illness.
For confirmed uncomplicated iron deficiency, oral ferrous sulfate, fumarate, or gluconate can work; a common starting amount is 40-65 mg elemental iron once daily or on alternate days. Alternate-day dosing may improve fractional absorption and reduce nausea, constipation, or metallic taste for many patients, although response and tolerance differ.
Hemoglobin should usually rise by about 1-2 g/dL over 2-4 weeks when anemia is due to iron deficiency and treatment is absorbed, but this is not a rigid rule. Lack of improvement should trigger checks for adherence, ongoing loss, wrong diagnosis, malabsorption, inflammation, or a coexisting condition rather than automatic dose escalation. See our practical guide to an iron supplement and retest plan.
Intravenous iron is often considered when oral treatment fails, cannot be tolerated, is unlikely to absorb, or rapid repletion is clinically needed. Different formulations deliver roughly 500-1,000 mg per infusion course, and they require medical supervision because infusion reactions, temporary hypophosphatemia with some products, and iron overload in the wrong setting are genuine concerns. The comparison of bisglycinate and sulfate may help with tolerability discussions, not with choosing a treatment alone.
Når lav transferrinmetning trenger rask medisinsk vurdering
Low TSAT needs prompt medical review when it accompanies significant anemia, possible bleeding, pregnancy, kidney disease, unexplained weight loss, or new cardiopulmonary symptoms. A result below 10% is not inherently an emergency, but the surrounding clinical picture can be.
Arrange timely review within days rather than months for hemoglobin below 10 g/dL, TSAT below 10% with symptoms, progressive fatigue, recurrent low results, or inability to tolerate oral intake. Pregnant people, children, older adults, and people receiving dialysis need more individualized thresholds because iron demands and consequences differ.
Seek urgent same-day care for chest pain, shortness of breath at rest, fainting, black tarry stool, vomiting dark granular material, severe ongoing menstrual loss, or visible rectal bleeding. These signs may reflect clinically significant anemia or active blood loss; an iron supplement is not a safe substitute for assessment.
Thomas Klein, MD, recommends bringing every prior CBC and iron panel to the appointment, not only the newest abnormal test. Kantesti AI can help arrange longitudinal values and questions for the visit, while our Medisinsk rådgivende styre provides physician oversight of our educational standards and our veiledning for AI-teknologi explains how contextual lab interpretation is designed.
Frequently Asked Questions
Hva forårsaker lav transferrinmetning?
Lav transferrinmetningsgrad skyldes oftest absolutt jernmangel, blodtap, lavt kostinntak, dårlig absorpsjon, inflammasjon, kronisk nyresykdom eller en kombinasjon av disse faktorene. En TSAT under 20% indikerer redusert sirkulerende jern tilgjengelighet i de fleste laboratorier for voksne, mens en verdi under 10% tyder på mer uttalt restriksjon. Ferritin, TIBC, hemoglobin, MCV, CRP, nyrefunksjon og symptomer avgjør hvilken årsak som er mest sannsynlig. Vedvarende lav TSAT bør vurderes klinisk, fordi behandling med jern alene kan overse blødning eller inflammatorisk sykdom.
Kan transferrinmetning være lav når ferritin er normalt?
Ja, transferrinmetningsgrad kan være lav med normal ferritin ved tidlig jernmangel og ved inflammasjon. Ferritin under 30 ng/mL kan støtte tidlig uttømte lagre selv om laboratorieintervallet starter ved 12 eller 15 ng/mL, særlig når TSAT er under 20% og TIBC er høy. Ved inflammasjon kan ferritin være 100 ng/mL eller høyere, mens hepcidin senker serumjern og TSAT. CRP eller ESR, trender i CBC, og noen ganger løselig transferrinreseptor bidrar til å skille disse mønstrene.
Er en transferrinmetning på 15% farlig?
En transferrinmetningsgrad på 15% er lav og krever oppfølging, men er ikke automatisk farlig eller en nødsituasjon i seg selv. Alvorlighetsgraden avhenger av hemoglobin, symptomer, graviditetsstatus, blødning, nyresykdom og hvor raskt svaret endret seg. TSAT på 15% med hemoglobin 13,5 g/dL og ingen symptomer kan vurderes rutinemessig, mens samme verdi med hemoglobin 8,5 g/dL, tungpust eller svart avføring krever rask oppfølging. En komplett jernstatus og CBC er mer informativt enn å bare gjenta TSAT.
Hvordan kan serumjern være normalt, men transferrinmetning lav?
Serumjern kan være lav-normal mens transferrinmetning er lav når TIBC er økt, noe som ofte oppstår når jernlagrene avtar. For eksempel gir serumjern på 65 µg/dL med TIBC på 400 µg/dL en TSAT på 16.25%, selv om 65 µg/dL kan ligge innenfor enkelte laboratorieintervaller. Serumjern varierer også i løpet av dagen og etter tilskudd, så den isolerte verdien kan være misvisende. TSAT-beregningen avslører om tilgjengelig jern er tilstrekkelig i forhold til transportkapasiteten.
Bør jeg ta jern ved lav transferrinmetning?
Jern kan være hensiktsmessig ved lav transferrinmetning når jernmangel er bekreftet, men årsaken bør vurderes før eller samtidig med behandling. Mange klinikere starter med 40–65 mg elementært oralt jern daglig eller annenhver dag ved ukomplisert mangel, og deretter gjentar hemoglobin og jernundersøkelser etter noen uker. Jern er ikke automatisk hensiktsmessig når ferritin er høyt, inflammasjon er aktiv, leversykdom foreligger, eller en hemoglobinsykdom er mulig. En kliniker kan avgjøre om peroralt jern, intravenøst jern, kildesøking eller observasjon er tryggest.
Hvor raskt bedres transferrinmetningen etter jernbehandling?
Transferrinmetning kan øke i løpet av dager etter peroral eller intravenøs jernbehandling, men en tidlig økning kan gjenspeile den nylige dosen snarere enn gjenopprettede kroppslagre. Hemoglobin stiger ofte med omtrent 1–2 g/dL i løpet av 2–4 uker når jernmangelanemi behandles effektivt, mens ferritinrestituering vanligvis tar lengre tid. Av denne grunn tolker klinikere ofte gjentatte resultater etter flere uker under konsistente prøvetakingsbetingelser. Pågående blodtap, inflammasjon, dårlig absorpsjon eller uteblitte doser kan bremse eller hindre bedring.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti Research Team. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo.. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti Research Team. (2026). aPTT Normal Range: D-Dimer, Protein C Blood Clotting Guide. Zenodo.. Kantesti AI Medical Research.
📖 External Medical References
Verdens helseorganisasjon (2020). WHO-retningslinje for bruk av ferritinkonsentrasjoner for å vurdere jernstatus hos individer og populasjoner. Verdens helseorganisasjon.
KDIGO Anemia Work Group (2012). KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements.
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.